Traditional chemotherapy is a cornerstone of cancer therapy, often used in combination with surgery and radiotherapy, particularly for metastatic cancer [1, 5]. However, a major limitation is the non-specificity of many conventional chemotherapeutic drugs [2]. These drugs are designed to destroy rapidly dividing cells, which unfortunately include not only cancer cells but also healthy, fast-growing cells throughout the body [1].
This widespread impact leads to a range of severe side effects, such as nausea, vomiting, pain, and a general feeling of unease (dysphoria) [1]. In the long term, systemic chemotherapy can cause irreversible damage to vital organs, including the kidneys and heart [1]. Furthermore, many anti-tumor drugs have low solubility, are cleared rapidly from the body, and achieve only low, uneven concentrations within tumors [2, 5]. The complex microenvironment of solid cancers, characterized by heterogeneous blood vessel density, high interstitial fluid pressure, and abundant supporting tissue (stroma), presents additional barriers to effective drug delivery [5].
The Promise of Targeted Drug Delivery
With increasing life expectancy, there is a growing demand for reliable cancer therapies that can spare or prevent damage to healthy, functional organs [1]. Targeted drug delivery systems represent a promising approach to address these challenges by precisely delivering therapeutic agents directly to specific tumor cells and tissues [1, 2, 7].
The primary goal of this strategy is to achieve optimal drug concentrations at the cancer site, thereby maximizing therapeutic efficacy while significantly minimizing exposure and harm to healthy cells and tissues [7]. This precision aims to reduce the severe systemic side effects commonly associated with conventional chemotherapy, improving patient safety and quality of life [3, 4, 7].
Nanotechnology's Role in Precision Treatment
Significant advancements in nanotechnology and its application in medicine have opened up new opportunities for cancer treatment, leading to the development of "smart" drug delivery systems [2, 4]. These systems frequently utilize nanoparticles, which are microscopic carriers designed to encapsulate and transport drugs [4, 6].
Nanoparticles enhance the intracellular delivery of drugs due to their unique properties, including multifunctionality and the ability to specifically target cancer cells [2]. When combined with nanotechnology, these smart drug delivery systems demonstrate a superior ability to reduce the side effects of chemotherapy compared to traditional drug delivery methods [4]. Studies have indicated that delivering chemotherapy via nanoscale carriers can offer greater therapeutic benefits than either treatment modality used alone [6]. Nanotechnology is hoped to overcome many of the drug delivery barriers present in tumors [5].
How Targeted Systems Work
Targeted drug delivery systems are engineered to overcome the inherent limitations of conventional cancer treatments by focusing their action. One key type involves polymer-based systems, which are favored for their ability to be customized. They can be designed to control the drug's release rate, extend its circulation time in the bloodstream, and ensure it is biocompatible (not harmful to the body) and biodegradable (breaks down naturally) [1].
Smart nanoparticles are another advanced approach. These carriers can be designed to respond to specific internal or external "triggers" that are characteristic of the tumor environment. Examples include changes in pH levels, elevated temperatures, or the presence of certain enzymes found predominantly in cancer cells. Upon encountering these triggers, the nanoparticles release their drug cargo precisely where it is needed [4].
These systems not only improve the stability of anti-cancer drugs, protecting them from premature degradation, but also enhance their ability to penetrate the challenging microenvironment of solid tumors, which often includes high interstitial fluid pressure and dense stroma [3, 5]. Beyond delivering single chemotherapy agents, targeted systems are being explored for combinatorial therapies. For instance, they can deliver chemotherapy drugs alongside phototherapy agents (light-based treatments), demonstrating the ability to enhance therapeutic effectiveness and reduce unwanted side effects through various mechanisms [3]. These systems also hold potential for advanced diagnostic imaging, providing a dual function [4].
Benefits and Future Directions
The primary advantages of targeted drug delivery systems are their potential to significantly enhance therapeutic efficacy and substantially reduce the severe, unwanted side effects and systemic toxicities associated with conventional chemotherapy [3, 6, 7]. By concentrating the therapeutic agents directly at the tumor site, these systems aim to improve patient outcomes, enhance their quality of life, and potentially extend survival by minimizing harm to healthy tissues [7].
Despite considerable progress in nanoparticle research and the development of smart drug delivery systems for cancer over the past decade, the molecular mechanisms involved are complex [4]. Ongoing research continues to explore novel types of nanoparticles, advanced triggering mechanisms, and innovative delivery strategies to further refine these treatments [4, 6]. The ultimate goal is to develop even more effective, precise, and safer cancer therapies that can overcome current treatment limitations and improve the lives of millions affected by cancer each year [4].
Sources
[1] Polymer-Based Drug Delivery Systems for Cancer. (Critical reviews in therapeutic drug carrier systems, 2018) https://pubmed.ncbi.nlm.nih.gov/30317968/
[2] Smart Drug-Delivery Systems for Cancer Nanotherapy. (Current drug targets, 2018) https://pubmed.ncbi.nlm.nih.gov/27231107/
[3] Recent progress in synergistic chemotherapy and phototherapy by targeted drug delivery systems for cancer treatment. (Artificial cells, nanomedicine, and biotechnology, 2018) https://pubmed.ncbi.nlm.nih.gov/29405791/
[4] Cancer Therapy Based on Smart Drug Delivery with Advanced Nanoparticles. (Anti-cancer agents in medicinal chemistry, 2019) https://pubmed.ncbi.nlm.nih.gov/30747081/
[5] Hyperthermia and smart drug delivery systems for solid tumor therapy. (Advanced drug delivery reviews, 2020) https://pubmed.ncbi.nlm.nih.gov/32092379/
[6] Nanoscale drug delivery for targeted chemotherapy. (Cancer letters, 2016) https://pubmed.ncbi.nlm.nih.gov/27235607/
[7] Intracranial Drug Delivery Devices: A Promising Approach for Future Epilepsy Treatment? (Current neuropharmacology, 2026) https://pubmed.ncbi.nlm.nih.gov/41863263/